Patent ID: 9730914
Date: 2017-08-15
CPC Classifications: A61K,A61P,C07D,C12N,C12Y

Claim:
1. A method for treating or ameliorating one or more symptoms of an RC-kinase-mediated disorder, disease, or condition in a subject, which comprises administering to the subject a compound of Formula I: or a stereoisomer, enantiomer, mixture of enantiomers, or mixture of diastereomers; or a pharmaceutically acceptable salt thereof; wherein: R R wherein each alkyl, cycloalkyl, aryl, heteroaryl or heterocyclyl is optionally substituted with one or more substituents q, where each q is independently selected from halo, c with the proviso that the compound is not 3-((3-chlorophenyl)amino)-5-((4-hydroxy-3,5-dimethylbenzyl)amino)-1h-pyrazole-4-carboxamide wherein the disorder, disease, or condition is asthma, exercise induced asthma, allergic rhinitis, atopic dermatitis, chronic obstructive pulmonary disease, allergic conjunctivitis, or fibrosis.